1-2 of 2
Authors: Samar Issa
Journal Article
CLRM-15 TRIAL IN PROGRESS: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT INHIBITOR OF BRUTON’S TYROSINE KINASE (BTKI) FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA (R/R PCNSL/SCNSL) AND PRIMARY VITREORETINAL LYMPHOMA (PVRL) Open Access
Neuro-Oncology Advances, Volume 4, Issue Supplement_1, August 2022, Page i9, https://doi.org/10.1093/noajnl/vdac078.035
Published: 05 August 2022
Journal Article
Extent of radiological response does not reflect survival in primary central nervous system lymphoma Open Access
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab007, https://doi.org/10.1093/noajnl/vdab007
Published: 15 February 2021
